EASD 2014:各国“抗糖”成果展示

2014-09-22 陈智、张永燊 CMT糖尿病

EASD 2014正式会议的第1天,除了开幕式及Claude Bernard奖颁奖以外,给小编留下最深印象的无疑是EASD在长长的会场走廊两侧给各国和糖尿病相关组织提供展位,供他们展示各国抗击糖尿病的成果。遗憾的是,几乎没有非洲国家进行展示。 首先来看看代表中国在EASD 2014展示的中华医学会糖尿病学分会(CDS)。CDS展示了我国在“世界糖尿病日”和历届CDS年会的宣传成果。小编拍

EASD 2014正式会议的第1天,除了开幕式及Claude Bernard奖颁奖以外,给小编留下最深印象的无疑是EASD在长长的会场走廊两侧给各国和糖尿病相关组织提供展位,供他们展示各国抗击糖尿病的成果。遗憾的是,几乎没有非洲国家进行展示。

首先来看看代表中国在EASD 2014展示的中华医学会糖尿病学分会(CDS)。CDS展示了我国在“世界糖尿病日”和历届CDS年会的宣传成果。小编拍摄期间恰逢EASD主席Boulton教授(左二)前来展位参观,图为Boulton教授等人与中华医学会工作人员合影。

国际糖尿病联盟(IDF)重点宣传“世界糖尿病日”

热爱体育的俄罗斯人,连宣传背板都涉及体育。

有趣的糖尿病心理社会因素研究组

我们的邻居哈萨克斯坦的展区

拉脱维亚的展示也很好看

乌克兰糖尿病联盟的展区,背板上的心形图案也曾出现在本报上

阿塞拜疆的展区

德国、澳大利亚、瑞士等国联合展示

吉尔吉斯斯坦的展区鲜花缭绕,很温馨的感觉

以色列的展区,重点突出该国糖尿病学会成立60周年。

以色列的邻居巴勒斯坦也设有展区,两国战争不断,但这并不妨碍在抗击糖尿病的路上成为“盟友”


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=26075, encodeId=bf89260e5aa, content=好好学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Fri Jun 05 16:26:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20584, encodeId=7ac52058403, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20585, encodeId=9a1120585be, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690585, encodeId=821b1690585e4, content=<a href='/topic/show?id=5c472843a1' target=_blank style='color:#2F92EE;'>#ASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2843, encryptionId=5c472843a1, topicName=ASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8529069357, createdName=okhuali, createdTime=Wed Aug 19 20:12:00 CST 2015, time=2015-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534079, encodeId=7fcb15340e993, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6436, encryptionId=576e643634, topicName=EASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21f812527653, createdName=qilu_qi, createdTime=Wed Sep 24 00:12:00 CST 2014, time=2014-09-24, status=1, ipAttribution=)]
    2015-06-05 ljjj1053

    好好学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=26075, encodeId=bf89260e5aa, content=好好学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Fri Jun 05 16:26:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20584, encodeId=7ac52058403, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20585, encodeId=9a1120585be, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690585, encodeId=821b1690585e4, content=<a href='/topic/show?id=5c472843a1' target=_blank style='color:#2F92EE;'>#ASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2843, encryptionId=5c472843a1, topicName=ASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8529069357, createdName=okhuali, createdTime=Wed Aug 19 20:12:00 CST 2015, time=2015-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534079, encodeId=7fcb15340e993, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6436, encryptionId=576e643634, topicName=EASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21f812527653, createdName=qilu_qi, createdTime=Wed Sep 24 00:12:00 CST 2014, time=2014-09-24, status=1, ipAttribution=)]
    2015-04-11 x35042875

    控制好糖尿病可能提高肝硬化患者的预后。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=26075, encodeId=bf89260e5aa, content=好好学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Fri Jun 05 16:26:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20584, encodeId=7ac52058403, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20585, encodeId=9a1120585be, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690585, encodeId=821b1690585e4, content=<a href='/topic/show?id=5c472843a1' target=_blank style='color:#2F92EE;'>#ASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2843, encryptionId=5c472843a1, topicName=ASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8529069357, createdName=okhuali, createdTime=Wed Aug 19 20:12:00 CST 2015, time=2015-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534079, encodeId=7fcb15340e993, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6436, encryptionId=576e643634, topicName=EASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21f812527653, createdName=qilu_qi, createdTime=Wed Sep 24 00:12:00 CST 2014, time=2014-09-24, status=1, ipAttribution=)]
    2015-04-11 x35042875

    控制好糖尿病可能提高肝硬化患者的预后。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=26075, encodeId=bf89260e5aa, content=好好学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Fri Jun 05 16:26:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20584, encodeId=7ac52058403, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20585, encodeId=9a1120585be, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690585, encodeId=821b1690585e4, content=<a href='/topic/show?id=5c472843a1' target=_blank style='color:#2F92EE;'>#ASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2843, encryptionId=5c472843a1, topicName=ASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8529069357, createdName=okhuali, createdTime=Wed Aug 19 20:12:00 CST 2015, time=2015-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534079, encodeId=7fcb15340e993, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6436, encryptionId=576e643634, topicName=EASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21f812527653, createdName=qilu_qi, createdTime=Wed Sep 24 00:12:00 CST 2014, time=2014-09-24, status=1, ipAttribution=)]
    2015-08-19 okhuali
  5. [GetPortalCommentsPageByObjectIdResponse(id=26075, encodeId=bf89260e5aa, content=好好学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Fri Jun 05 16:26:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20584, encodeId=7ac52058403, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20585, encodeId=9a1120585be, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690585, encodeId=821b1690585e4, content=<a href='/topic/show?id=5c472843a1' target=_blank style='color:#2F92EE;'>#ASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2843, encryptionId=5c472843a1, topicName=ASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8529069357, createdName=okhuali, createdTime=Wed Aug 19 20:12:00 CST 2015, time=2015-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534079, encodeId=7fcb15340e993, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6436, encryptionId=576e643634, topicName=EASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21f812527653, createdName=qilu_qi, createdTime=Wed Sep 24 00:12:00 CST 2014, time=2014-09-24, status=1, ipAttribution=)]
    2014-09-24 qilu_qi

相关资讯

EASD 2014:心衰伴2型糖尿病患者死亡风险增加70%

瑞典卡洛林斯卡研究所的Anna Norhammar博士和Isabelle Johansson博士在欧洲糖尿病学会年会上发表了一项研究,其结果显示,在缺血性心衰患者当中,2型糖尿病在2年内增加死亡风险70%。即使是之前接受了血运重建术的患者死亡风险也增加了60%。在射血分数≥50%的患者中则稍低一些,2型糖尿病使他们的死亡风险增加了40%。研究结果来自瑞典心衰注册体系,包含自2003年以来约41,0

EASD 2014:第50届欧洲糖尿病研究学会年会预告

欧洲糖尿病年会(EASD)于1956年在意大利蒙特卡蒂尼由Dr. Joseph Hoet作为主席而创办。目前EASD的正式会员已经超过了5,500人,这些会员来自全世界100多个国家。对糖尿病研究做出过杰出贡献的医生或科学家会被授予荣誉会员,学会的第一位荣誉会员是Charles Best。50届欧洲糖尿病研究协会((European Association for the Study of

EASD 2014:达格列净可安全应用于高血压糖尿病患者

 欧洲糖尿病研究学会(EASD)2014年会的一项报告表明,在高血压控制不佳的2型糖尿病患者中,达格列净(dapagliflozin)与血管紧张素转换酶抑制剂(ACEI)或血管紧张素受体拮抗剂(ARB)联用具有良好的安全性。 两项为期12周的随机、双盲研究以血糖(HbA1c 7.0-10.5%))和血压(BP: 140-164 / 85-104 mmHg)控制不佳的2型糖尿病患

EASD 2014大会日程概览

        于奥地利维也纳召开的欧洲糖尿病研究学会(EASD)2014年会将迎来50华诞,预计将有近20000位与会者参加此次大会,预计规模超过国际糖尿病联盟(IDF)和美国糖尿病学会(ADA)会议。         以下为会

EASD2012:中国口服降糖药应用状况堪忧

  2012年EASD大会上,中国学者进行了3场口头报告和19项壁报展示。其中,北京大学人民医院的一项报告表明,胰岛素促泌剂为中国2型糖尿病患者最常用的口服降糖药,并可能是低血糖高发和血糖控制不佳的原因。应用磺脲类或格列奈类单药治疗的患者更有可能改变治疗方案,疗效不佳为其主要原因。   研究背景   中国拥有世界最大的糖尿病人群,20岁以上糖尿病患者接近1亿。基于循证医学指南的糖尿病管理和治疗

EASD 2013:常用降血糖药物不增加腺癌风险

流行病学研究提示某些降血糖药物可能会增加或降低2型糖尿病患者癌症的风险。为了比较不同降血糖药物相关腺癌发生的风险,来自荷兰伊拉斯姆斯大学Airin Simon教授及其团队进行了一项研究,该研究发现常用降血糖药物对腺癌发生无影响。该研究结果发表在2013年EASD会议上。该研究中,在荷兰初级保健研究数据库(IPCI)1996-2011年期间的2型糖尿病患者(29383例)中间进行一项病例对照研究。入